Your Health, We Care
Pemigatinib is a targeted therapy drug primarily used for the treatment of cholangiocarcinoma. The main specification of Pemigatinib is 4.5mg/14Tablets, with a price of approximately $194.
Please note that the above prices are for reference only, and actual prices may vary due to factors such as region, sales channels, promotional activities, etc.
Pemigatinib is used in adults to treat bile duct cancer that has spread to other···【more】
Release date：2024-08-13Recommended：152
Pemigatinib is a targeted therapy drug developed by Incyte in the United States,···【more】
Release date：2024-08-12Recommended：145
Pemigatinib is a potent and selective oral antineoplastic drug targeting the FGF···【more】
Release date：2024-08-09Recommended：109
